NovaBay Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. NovaBay Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2% to $14,726,000. The net income raised on -$9,640,000 and profit margin reached -65%. Total operating expenses were $12,898,000.
Profit Margin
| 2014 | 1.05M | -15.19M | -1441.56% |
|---|---|---|---|
| 2015 | 4.38M | -18.97M | -433.07% |
| 2016 | 11.89M | -13.15M | -110.54% |
| 2017 | 18.23M | -7.40M | -40.61% |
| 2018 | 12.50M | -6.54M | -52.33% |
| 2019 | 6.59M | -10.48M | -158.92% |
| 2020 | 9.93M | -11.03M | -111.12% |
| 2021 | 8.42M | -6.55M | -77.89% |
| 2022 | 14.40M | -16.26M | -112.92% |
| 2023 | 14.72M | -9.64M | -65.46% |
NBY Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 14.72M | 14.40M | 8.42M | 9.93M | 6.59M | 12.50M | 18.23M | 11.89M | 4.38M | 1.05M |
Cost of revenue | 6.83M | 6.62M | 2.77M | 3.97M | 1.73M | 1.50M | 2.78M | 2.46M | 1.26M | 486K |
Gross profit | 7.89M | 7.78M | 5.64M | 5.96M | 4.86M | 11.00M | 15.44M | 9.43M | 3.12M | 568K |
Operating exp. | ||||||||||
Research and development | 68K | 174K | 44K | 285K | 184K | 259K | 410K | 1.37M | 6.04M | 9.51M |
Selling and marketing | 6.5M | 7.79M | 7.22M | 6.17M | 8.76M | 12.78M | 13.71M | 11.80M | 10.52M | 1.75M |
Total operating expenses | 12.89M | 15.46M | 14.50M | 12.39M | 14.26M | 18.87M | 22.75M | 20.41M | 24.13M | 17.44M |
Operating income | -5.00M | -7.68M | -8.86M | -6.42M | -9.4M | -7.87M | -7.31M | -10.98M | -21.01M | -16.87M |
Other income (expenses), net | -4.63M | -2.92M | 3.03M | -4.60M | -252K | 1.33M | -89K | -2.16M | 2.04M | 1.71M |
Income before tax | -9.64M | -10.60M | -5.82M | -11.03M | -9.65M | -6.54M | -7.4M | -13.14M | -18.97M | -15.19M |
Income tax expense | 0 | -3.80M | -4.61M | 5K | 6K | 4K | 3K | 2K | 12K | 2K |
Net income | -9.64M | -16.26M | -6.55M | -11.03M | -10.48M | -6.54M | -7.40M | -13.15M | -18.97M | -15.19M |
Earnings per share | ||||||||||
Basic EPS | -138.65 | -10.1 | -5.26 | -385.53 | -16.96 | -13.54 | -591.81 | -49 | 0 | 0 |
Diluted EPS | -138.65 | -10.1 | -5.26 | -385.53 | -16.96 | -13.43 | -591.81 | -48.92 | 0 | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |